s6y
Company name or ticker
Search
Veraxa Biotech AG - Post de-SPAC
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Filed
Tuesday, September 30, 2025
Accession number
0001829126-25-007783
Documents
425
425
On sec.gov
Filing index
All files
Complete submission text
SGML header